MedPath

Succinylcholine Chloride

Succinylcholine Chloride Injection, USP

Approved
Approval ID

53e064bb-f71c-485f-b466-58a0739e7753

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 25, 2020

Manufacturers
FDA

Indoco Remedies Limited

DUNS: 650445950

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Succinylcholine Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code14445-407
Application NumberANDA214308
Product Classification
M
Marketing Category
C73584
G
Generic Name
Succinylcholine Chloride
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 25, 2020
FDA Product Classification

INGREDIENTS (6)

Succinylcholine ChlorideActive
Quantity: 20 mg in 1 mL
Code: I9L0DDD30I
Classification: ACTIB
METHYLPARABENInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
PROPYLPARABENInactive
Quantity: 0.20 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Succinylcholine Chloride - FDA Drug Approval Details